Skip to main content
. 2020 Jun 16;9(6):1878. doi: 10.3390/jcm9061878
CCRT concurrent chemoradiotherapy
CI confidence interval
DFS disease-free survival
18F-FDG PET/CT F-18 fluorodeoxyglucose positron emission tomography/computed tomography
FIGO Advanced International Federation of Gynecology and Obstetrics
HF heterogeneity factor
HR hazard ratio
SUVmax maximum standardized uptake value
MTV metabolic tumor volume
ROC receiver operating characteristic
TLG total lesion glycolysis
WB whole body